NANOLOGICA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.38 SEK | -0.62% |
|
+12.72% | -38.65% |
| Apr. 26 | Nanologica AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 11 | Nanologica's New COO to Take Office in May | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 174.5 | 372.2 | 385.9 | 281.7 | 375.9 | 281.9 | - | - |
| Enterprise Value (EV) 1 | 182.6 | 372.2 | 385.9 | 279.3 | 375.9 | 281.9 | 281.9 | 281.9 |
| P/E ratio | -8.9 x | -14.4 x | -8.56 x | -5.43 x | - | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 17.1 x | 23.1 x | 29.9 x | 181 x | 261 x | 4.59 x | 1.67 x | 1.12 x |
| EV / Revenue | 17.1 x | 23.1 x | 29.9 x | 181 x | 261 x | 4.59 x | 1.67 x | 1.12 x |
| EV / EBITDA | -11 x | - | -12.8 x | -7.22 x | -7.43 x | -12.3 x | 7.87 x | 4.11 x |
| EV / FCF | -3.71 x | - | -7.18 x | -5.38 x | -6.62 x | -8.29 x | 14.1 x | - |
| FCF Yield | -27% | - | -13.9% | -18.6% | -15.1% | -12.1% | 7.1% | - |
| Price to Book | - | - | 7.49 x | 4.94 x | - | - | - | - |
| Nbr of stocks (in thousands) | 16,619 | 27,777 | 28,166 | 28,166 | 36,146 | 44,179 | - | - |
| Reference price 2 | 10.50 | 13.40 | 13.70 | 10.00 | 10.40 | 6.380 | 6.380 | 6.380 |
| Announcement Date | 2/7/20 | 2/26/21 | 2/8/22 | 2/10/23 | 2/2/24 | - | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 10.23 | 16.14 | 12.91 | 1.555 | 1.443 | 61.4 | 168.4 | 252.5 |
| EBITDA 1 | -15.89 | - | -30.23 | -38.99 | -50.6 | -23 | 35.8 | 68.5 |
| EBIT 1 | -19.22 | - | -40.69 | -50.85 | -69.96 | -42.7 | 16.7 | 44.4 |
| Operating Margin | -187.96% | - | -315.08% | -3,270.1% | -4,848.44% | -69.54% | 9.92% | 17.58% |
| Earnings before Tax (EBT) | -19.59 | - | -44.83 | -55.23 | - | - | - | - |
| Net income | -19.59 | - | -44.83 | -55.23 | - | - | - | - |
| Net margin | -191.53% | - | -347.13% | -3,551.83% | - | - | - | - |
| EPS | -1.180 | -0.9300 | -1.600 | -1.840 | - | - | - | - |
| Free Cash Flow 1 | -47.04 | - | -53.74 | -52.36 | -56.83 | -34 | 20 | - |
| FCF margin | -459.93% | - | -416.15% | -3,367.27% | -3,938.18% | -55.37% | 11.88% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 55.87% | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 2/7/20 | 2/26/21 | 2/8/22 | 2/10/23 | 2/2/24 | - | - | - |
1SEK in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.676 | 0.27 | 0.21 | 0.401 | 0.674 | - | 0.672 | - | 0.075 | - | 9.4 | 18.1 | 28.9 |
| EBITDA 1 | -11.25 | -12.7 | -9.487 | -6.646 | - | - | -9.686 | -6.546 | -26.91 | - | -8.1 | -5 | -2.3 |
| EBIT 1 | -14.11 | -15.59 | -12.4 | -9.61 | - | - | -13.31 | -10.29 | -35.64 | - | -11.4 | -8.7 | -7.4 |
| Operating Margin | -2,086.98% | -5,774.81% | -5,903.33% | -2,396.51% | - | - | -1,980.95% | - | -47,517.33% | - | -121.28% | -48.07% | -25.61% |
| Earnings before Tax (EBT) | -15.22 | -15.92 | -13.47 | -10.99 | - | - | - | - | - | - | - | - | - |
| Net income | -15.22 | -15.92 | -13.47 | -10.99 | - | -12.09 | - | - | - | -16.77 | - | - | - |
| Net margin | -2,251.78% | -5,894.44% | -6,415.71% | -2,740.15% | - | - | - | - | - | - | - | - | - |
| EPS | -0.5400 | -0.5700 | -0.4800 | -0.3900 | - | -0.3300 | - | - | - | -0.4600 | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/8/22 | 4/29/22 | 8/19/22 | 11/11/22 | 2/10/23 | 4/28/23 | 7/7/23 | 10/27/23 | 2/2/24 | 4/26/24 | - | - | - |
1SEK in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | 8.07 | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | 2.39 | - | - | - | - |
| Leverage (Debt/EBITDA) | -0.5077 x | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -47 | - | -53.7 | -52.4 | -56.8 | -34 | 20 | - |
| ROE (net income / shareholders' equity) | -141% | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | 1.830 | 2.020 | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | - | 7.25 | 7.14 | 1.76 | 3 | 1 | - |
| Capex / Sales | - | - | 56.13% | 459.29% | 121.69% | 4.89% | 0.59% | - |
| Announcement Date | 2/7/20 | 2/26/21 | 2/8/22 | 2/10/23 | 2/2/24 | - | - | - |
1SEK in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -38.65% | 26.49M | |
| +8.02% | 41.62B | |
| -21.54% | 22.23B | |
| -14.02% | 13.5B | |
| -8.19% | 10.28B | |
| -6.23% | 9.92B | |
| +23.18% | 8.53B | |
| +11.62% | 6.72B | |
| -27.51% | 5.57B | |
| -20.56% | 3.74B |
- Stock Market
- Equities
- NICA Stock
- Financials Nanologica AB
